CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Advances in the study of mechanisms of the tumor angiogenesis inhibitors
Xiao, D; Ding, J
1999-07
卷号30
期号3
页码219-23
英文摘要Tumor angiogenesis inhibitor is the drugs which can destroy or inhibit neovascularization, and block the growth and metastasis of cancer. For clinical applications it may be useful to divide the antiangiogenic drugs into two categories: class 1(specific inhibitors) and class 2 (non-specific inhibitors). This review intends to provide the recent progress of the mechanisms of antiangiogenic drugs (1) Regulation of angiogenesis growth factors; (2) Inhibition of basement membrane degradation; (3) Mediating signal transduction pathway; (4) Effect of cell cycle; (5) Regulation of tumor-related gene.
会议录Sheng li ke xue jin zhan [Progress in physiology]
文献子类Meeting Abstract;Article;Review
语种中文
内容类型会议论文
源URL[http://119.78.100.183/handle/2S10ELR8/266928]  
专题中国科学院上海药物研究所
作者单位Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031
推荐引用方式
GB/T 7714
Xiao, D,Ding, J. Advances in the study of mechanisms of the tumor angiogenesis inhibitors[C]. 见:.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace